Information:
Error:
ID
13343
Description
Prozac Treatment of Major Depression: Discontinuation Study; ODM derived from: https://clinicaltrials.gov/show/NCT00427128
Link
https://clinicaltrials.gov/show/NCT00427128
Keywords
Versions (1)
- 2/7/16 2/7/16 -
Uploaded on
February 7, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Major Depression NCT00427128
Eligibility Major Depression NCT00427128
- StudyEvent: Eligibility
Similar models
Eligibility Major Depression NCT00427128
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
gender, age
Item
1. men and women ages 18-65
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
major depression dsm iv
Item
2. meets criteria for dsm iv major depression
boolean
C1269683 (UMLS CUI [1])
informed consent
Item
3. signs informed consent and able to comply with study
boolean
C0021430 (UMLS CUI [1])
pregnant women, childbearing potential, contraceptive methods
Item
1. pregnant women and women of child-bearing potential who are not using a medically accepted means of contraception.
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C3831118 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
oral contraceptives, breast feeding
Item
2. women taking oral contraceptives, the initiation of which was temporally associated with the onset of depression; women who are breast-feeding.
boolean
C0700589 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
suicidal risk
Item
3. patients with serious suicidal risk, including any patient who became suicidal with previous discontinuation of an antidepressant.
boolean
C0438696 (UMLS CUI [1])
seizure disorder
Item
4. patients with a history of seizure disorder.
boolean
C0014544 (UMLS CUI [1])
unstable physical disorders or any physical disorder affecting cns function
Item
5. patients with unstable physical disorders (cardiovascular, hepatic, renal, respiratory, endocrine, neurologic, or hematologic) or any physical disorder judged to significantly affect cns function.
boolean
C0009488 (UMLS CUI [1])
psychiatric comorbidities
Item
6. patients meeting criteria for the following dsm-iv diagnoses: organic mental disorders; substance use disorders, including alcohol, active within the last 6 months; schizophrenia; delusional disorder; psychotic disorders; bipolar disorder; antisocial personality disorder; or presence of psychotic features
boolean
C0349095 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
C0036341 (UMLS CUI [3])
C0011251 (UMLS CUI [4])
C0033975 (UMLS CUI [5])
C0005586 (UMLS CUI [6])
C0003431 (UMLS CUI [7])
C0459435 (UMLS CUI [8])
C0038586 (UMLS CUI [2])
C0036341 (UMLS CUI [3])
C0011251 (UMLS CUI [4])
C0033975 (UMLS CUI [5])
C0005586 (UMLS CUI [6])
C0003431 (UMLS CUI [7])
C0459435 (UMLS CUI [8])
response to treatment with ssri
Item
7. patients with a history of non-response to an adequate trial of a selective serotonin reuptake inhibitor in a past or current depressive episode, defined as a four-week trial of a minimum of 40mg/day of fluoxetine or paroxetine, or 100mg/day of sertraline.
boolean
C0360105 (UMLS CUI [1,1])
C0521982 (UMLS CUI [1,2])
C0521982 (UMLS CUI [1,2])
medication other
Item
8. concurrent use of exclusionary drugs
boolean
C0013227 (UMLS CUI [1])
hypothyroidism
Item
9. clinical or laboratory evidence of hypothyroidism without adequate stable replacement (eg, low total t4 or elevated tsh by a high sensitivity method).
boolean
C0020676 (UMLS CUI [1])